Posts by edc_admin
First studies started in Japan
Key Milestones in Japan In May 2018, RealWorld EDC passed its first audit by a Japanese CRO. The following month- in June, the Company passed a Japanese pharma audit. We started our first two studies in Japan in 2018 for two of the leading Japanese pharmaceuticals companies in two therapeutic areas: Ophthalmology and Biological Medicine.
Read MoreCTEP Cloud Usage paper published in ACDMs Data Matters (Winter 2015)
White paper on cost of running NIS studies in the Cloud for Pharma..
Read MoreCTEP NIS paper published in SCDM Data Basics (Winter 2015)
White paper on rules to better data management and Pharmacovigilance in NIS
Read MoreSurvey Results from over 460 Users in Russia
Collecting real world evidence in a local market is becoming increasingly important for a variety of reasons. It raises product awareness with local key opinion leaders (KOLs), gathers data to support health technology assessments, satisfies safety requirements for regulators and demonstrates the value of new medicines in the market.
Read MoreTomas O’Mahoney presented at ACDM Conference 2015
CTEP’s Head of Operations Tomas O’Mahoney presented at the 2015 annual ACDM (Association of Clinical Data Management) Conference on the topic of non-interventional studies. Tomas presented his topic “Making BIG DATA smaller… Non intervention (NI) studies – 7 simple rules to better data management and 4+1 for improved pharmacovigilance in NI studies” at the industry-leading conference.
Read MoreCTEP ACDM paper “PARAs must fit”
Tomás O’Mahoney, Operations Director, writes in the Association for Clinical Data Management’s journal Data Matters on “PARAs must be fit”.
Read More